Differential benefit of adjuvant docetaxel-based chemotherapy in patients with early breast cancer according to baseline body mass index

- Desmedt, Christine, Fornili, Marco, Sotiriou, Christos, Piccart, Martine, Biganzoli, Elia, Clatot, Florian, Demicheli, Romano, De Bortoli, Davido, Di Leo, Angelo, Viale, Giuseppe, de Azambuja, Evandro, Crown, John, Francis, Prudence A.

Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

- Sonnenblick, Amir, Francis, Prudence A., Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Barnadas, Agusti, Cortes-Funes, Hernan, Piccart, Martine, Crown, John, Azim Jr, Hatem A., de Azambuja, Evandro, Nordenskjold, Bo, Gutierez, Jorge, Quinaux, Emmanuel, Mastropasqua, Mauro G., Ameye, Lieveke, Anderson, Michael

p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial

- Sonnenblick, Amir, Salgado, Roberto, Crown, John, Viale, Giuseppe, Daly, Laura, Javdan, Bahar, Fujisawa, Sho, de Azambuja, Evandro, Lieveke, Ameye, Piccart, Martine, Bromberg, Jacqueline, Sotirou, Christos, Brohee, Sylvain, Zahavi, Tamar, Peretz, Tamar, van den Eynden, Gert, Rouas, Ghizlaine, Salmon, Asher, Francis, Prudence A., Di Leo, Angelo

Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the Breast International Group 02-98 Trial

- Zeidan, Youssef H., Habib, Joyce G., Ameye, Lieveke, Paesmans, Marianne, de Azambuja, Evandro, Gelber, Richard D., Campbell, Ian, Nordenskjöld, Bo, Gutiérez, Jorge, Anderson, Michael, Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Joseph, David J., Crown, John, Piccart-Gebhart, Martine, Francis, Prudence A.